— Know what they know.
Not Investment Advice

ISPC NASDAQ

iSpecimen Inc.
1W: -17.5% 1M: -30.2% 3M: -59.5% YTD: -90.9% 1Y: -97.9% 3Y: -99.8% 5Y: -100.0%
$1.08
-0.06 (-5.26%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 30 · $2.7M mcap · 3M float · 21.01% daily turnover · Short 26% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$9M -6.4% ▼
5Y CAGR: +16.7%
Gross Profit
$4M -21.9% ▼
5Y CAGR: +12.9%
Operating Income
-$13M -14.0% ▼
Net Income
-$12M -12.6% ▼
EPS (Diluted)
$-17.58 +28.4% ▲
EBITDA
-$13M -44.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$8M$11M$10M$10M$9M
YoY Growth+90.4%+36.1%-6.6%-4.6%-6.4%
Cost of Revenue$4M$5M$5M$5M$5M
Gross Profit$5M$6M$6M$5M$4M
Gross Margin56.2%52.9%54.3%51.4%42.9%
R&D Expenses$1M$2M$3M$4M$4M
SG&A Expenses$5M$9M$12M$12M$13M
Operating Expenses$7M$12M$16M$16M$17M
Operating Income-$2M-$6M-$10M-$11M-$13M
Operating Margin-29.4%-53.2%-97.9%-112.5%-137.0%
Interest Expense$2M$2M$239K$231K$220K
Income Before Tax-$5M-$9M-$10M-$11M-$12M
Tax Expense$0$0$0$0$0
Net Income-$5M-$9M-$10M-$11M-$12M
Net Margin-56.8%-80.5%-98.5%-111.8%-134.5%
EPS (Diluted)$-144.38$-24.51$-20.44$-24.55$-17.58
EBITDA-$2M-$6M-$9M-$9M-$13M
Shares Outstanding46811408624442215452067710852

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms